Protein kinase G regulates the basal tension and plays a major role in nitrovasodilator-induced relaxation of porcine coronary veins

British Journal of Pharmacology

Volumn 152, Issue 7, 2007, Pages 1060-1069

  Qi, H ^a   Zheng, X ^a   Qin, X ^a   Dou, D ^a   Xu, H ^a   Raj, J U ^b   Gao, Y ^a,c  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c PEKING UNIVERSITY   (China)

Author keywords

Myristoylated PKI; Nitric oxide; Rp 8 Br PET cGMPS

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; 2,2 HYDROXYNITROSOHYDRAZONO BIS ETHENAMINE; 3,3 BIS(2 AMINOETHYL) 1 HYDROXY 2 OXOTRIAZENE; 8 BROMO ADENOSINE 3'5' CYCLIC MONOPHOSPHATE; 8 BROMO GUANOSINE 3'5' CYCLIC MONOPHOSPHATE; BETA PHENYL 1, N 2 ETHENO 8 BROMOGUANOSINE 3'5' CYCLIC MONOPHOSPHOROTHIOATE; CORONARY VASODILATING AGENT; CYCLIC AMP; CYCLIC GMP; CYCLIC GMP DEPENDENT PROTEIN KINASE; CYCLIC GMP DEPENDENT PROTEIN KINASE INHIBITOR; GLYCERYL TRINITRATE; INDOMETACIN; MYRISTOYL PROTEIN KINASE INHIBITOR; NITRIC OXIDE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY VEIN; DRUG EFFECT; DRUG MECHANISM; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RADIOIMMUNOASSAY; VASODILATATION;

ANIMALS; CORONARY VESSELS; CYCLIC AMP-DEPENDENT PROTEIN KINASES; CYCLIC GMP; CYCLIC GMP-DEPENDENT PROTEIN KINASES; DOSE-RESPONSE RELATIONSHIP, DRUG; NITRIC OXIDE; NITROGLYCERIN; NITROSO COMPOUNDS; ORGAN CULTURE TECHNIQUES; PROTEIN KINASE INHIBITORS; RADIOIMMUNOASSAY; SWINE; THIONUCLEOTIDES; VASODILATION; VASODILATOR AGENTS; VEINS;

EID: 36448973861     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/sj.bjp.0707479     Document Type: Article

References (51)

1. Ca channel in airway smooth muscle by nitric oxide: involvement of a nitrothiosylation mechanism? Am J Respir Cell Mol Biol 19: 485-497.
2. Algara-Suarez P, Espinosa-Tanguma R (2004). 8-Br-cGMP mediates relaxation of tracheal smooth muscle through PKA. Biochem Biophys Res Commun 314: 597-601.
3. Banitt PF, Dai HB, Wang SY, Friedman M, Sellke FW (1995). Myogenic and agonist induced responses of coronary venules after cold hyperkalaemic cardioplegia. Cardiovasc Res 29: 827-833.
4. 2+ sensitivity by cyclic nucleotides in smooth muscle from protein kinase G-deficient mice. J Biol Chem 279: 5146-5151.
5. Bradford MM (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye-binding. Anal Chem 72: 249-254.
6. Butt E, Pohler D, Genieser HG, Huggins JP, Bucher B (1995). Inhibition of cyclic GMP-dependent protein kinase-mediated effects by (Rp)-8-bromo-PET-cyclic GMPS. Br J Pharmacol 116: 3110-3116.
7. Cassin S (1980). Role of prostaglandins and thromboxanes in the control of the pulmonary circulation in the fetus and newborn. Semin Perinatol 4: 101-107.
8. Chilian WM, Layne SM, Eastham CL, Marcus ML (1989). Heterogeneous microvascular coronary alpha-adrenergic vasoconstriction. Circ Res 64: 376-388.
9. Cocks TM, Broughton A, Dib M, Sudhir K, Angus JA (1989a). Endothelin is blood vessel selective: studies on a variety of human and dog vessels in vitro and on regional blood flow in the conscious rabbit. Clin Exp Pharmacol Physiol 16: 243-246.
10. Cocks TM, Faulkner NL, Sudhir K, Angus J (1989b). Reactivity of endothelin-1 on human and canine large veins compared with large arteries in vitro. Eur J Pharmacol 171: 17-24.
11. Colbran JL, Francis SH, Leach AB, Thomas MK, Jiang H, McAllister LM et al. (1992). A phenylalanine in peptide substrates provides for selectivity between cGMP- and cAMP-dependent protein kinases. J Biol Chem 267: 9589-9594.
12. Coleman RA, Humphrey PP, Kennedy I, Levy GP, Lumley P (1981). Comparison of the actions of U-46619, a prostaglandin H2-analogue, with those of prostaglandin H2 and thromboxane A2 on some isolated smooth muscle preparations. Br J Pharmacol 73: 773-778.
13. Dhanakoti S, Gao Y, Nguyen MQ, Raj JU (2000). Involvement of cGMP-dependent protein kinase in the relaxation of ovine pulmonary arteries to cGMP and cAMP. J Appl Physiol 88: 1637-1642.
14. Drexler H (1999). Nitric oxide and coronary endothelial dysfunction in humans. Cardiovasc Res 43: 572-579.
15. Francis SH, Blount MA, Zoraghi R, Corbin JD (2005). Molecular properties of mammalian proteins that interact with cGMP: protein kinases, cation channels, phosphodiesterases, and multidrug anion transporters. Front Biosci 10: 2097-2117.
16. Francis SH, Corbin JD (1994). Progress in understanding the mechanism and function of cyclic GMP-dependent protein kinase. Adv Pharmacol 26: 115-170.
17. Francis SH, Noblett BD, Todd BW, Wells JN, Corbin JD (1988). Relaxation of vascular and tracheal smooth muscle by cyclic nucleotide analogs that preferentially activate purified cGMP-dependent protein kinase. Mol Pharmacol 34: 506-517.
18. Galindo BE, Beltrán C, Cragoe EJ, Darszon A (2000). Participation of a K(+) channel modulated directly by cGMP in the speract-induced signaling cascade of strongylocentrotus purpuratus sea urchin sperm. Dev Biol 221: 285-294.
19. Galindo BE, de la Vega-Beltran JL, Labarca P, Vacquier VD, Darszon A (2007). Sp-tetraKCNG: A novel cyclic nucleotide gated K(+) channel. Biochem Biophys Res Commun 354: 668-675.
20. Gao Y, Dhanakoti S, Tolsa J-F, Raj JU (1999). Role of protein kinase G in nitric oxide- and cGMP-induced relaxation of newborn ovine pulmonary veins. J Appl Physiol 87: 993-998.
21. 2 cause greater relaxations in pulmonary veins than in arteries of newborn lambs. J Appl Physio 81: 2534-2539.
22. Gao Y, Zhou H, Raj JU (1995). Endothelium-derived nitric oxide plays a larger role in pulmonary veins than in arteries of newborn lambs. Cir Res 76: 559-565.
23. Garthwaite J, Southam E, Boulton CL, Nielsen EB, Schmidt K, Mayer B (1995). Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one. Mol Pharmacol 48: 184-188.
24. Glass DB, Cheng HC, Mende-Mueller L, Reed J, Walsh DA (1989). Primary structural determinants essential for potent inhibition of cAMP-dependent protein kinase by inhibitory peptides corresponding to the active portion of the heat-stable inhibitor protein. J Biol Chem 264: 8802-8810.
25. Gordon AM, Huxley AF, Julian FJ (1966). The variation in isometric tension with sarcomere length in vertebrate muscle fibres. J Physiol (London) 184: 170-192.
26. Gulbenkian S, Saetrum Opgaard O, Barroso CP, Wharton J, Polak JM, Edvinsson L (1994). The innervation of guinea pig epicardial coronary veins: Immunohistochemistry, ultrastructure and vasomotility. J Auton Nerv Syst 47: 201-212.
27. + channel in mouse neocortical neurons by nitric oxide. J Neurophysiol 95: 2167-2178.
28. Hofmann F, Feil R, Kleppisch T, Schlossmann J (2006). Function of cGMP-dependent protein kinases as revealed by gene deletion. Physiol Rev 86: 1-23.
29. Ignarro LJ (1990). Biosynthesis and metabolism of endothelium-derived nitric oxide. Annu Rev Pharmacol Toxicol 30: 535-560.
30. Janssen LJ, Premji M, Lu-Chao H, Cox G, Keshavjee S (2000). NO(+) but not NO radical relaxes airway smooth muscle via cGMP-independent release of internal Ca(2+). Am J Physiol 278: L899-L905.
31. Kawada T, Toyosato A, Islam MO, Yoshida Y, Imai S (1997). cGMP-kinase mediates cGMP- and cAMP-induced Ca2+ desensitization of skinned rat artery. Eur J Pharmacol 323: 75-82.
32. Kuo L, Arko F, Chilian WM, Davis MJ (1993). Coronary venular responses to flow and pressure. Circ Res 72: 607-615.
33. 2+ desensitization in vascular smooth muscle by activating the myosin light chain phosphatase. J Biol Chem 272: 5063-5068.
34. 2+ by Camp in vascular smooth muscle cells. Am J Physiol 258: C399-C407.
35. Lincoln TM, Dey N, Sellak H (2001). Invited review: cGMP-dependent protein kinase signaling mechanisms in smooth muscle: from the regulation of tone to gene expression. J Appl Physiol 91: 1421-1430.
36. Lohmann SM, Vaandrager AB, Smolenski A, Walter U, De Jonge HR (1997). Distinct and specific functions of cGMP-dependent protein kinases. Trends Biochem Sci 22: 307-312.
37. Meyer Jr RB, Miller JP (1974). Analogs of cyclic AMP and cyclic GMP: general methods of synthesis and the relationship of structure to enzymic activity. Life Sci 14: 1019-1040.
38. Moncada S, Palmer RM, Higgs EA (1991). Nitric oxide: physiology, pathology, and pharmacology. Pharmacol Rev 43: 109-142.
39. 5-[imino (nitroamino) methyl]-L-ornithine) impairs endothelium-dependent dilations by inhibiting cytosolic nitric oxide synthesis from L-arginine. Naunyn-Schmiedeberg's Arch Pharmacol 341: 143-147.
40. Nelson MT, Quayle JM (1995). Physiological roles and properties of potassium channels in arterial smooth muscle. Am J Physiol 268: C799-C822.
41. Qin X, Zheng X, Qi H, Dou D, Raj JU, Gao Y (2007). cGMP-dependent protein kinase in regulation of basal tone and in nitroglycerin- and nitric-oxide-induced relaxation in porcine coronary artery. Pflugers Arch Eur J Physiol 454: 913-923.
42. Saetrum Opgaard O, Cantera L, Adner M, Edvinsson L (1996). Endothelin-A and -B receptors in human coronary arteries and veins. Regul Pept 63: 149-156.
43. Saetrum Opgaard O, Edvinsson L (1997). Mechanical properties and effects of sympathetic co-transmitters on human coronary arteries and veins. Basic Res Cardiol 92: 168-180.
44. Saetrum Opgaard O, Gulbenkian S, Bergdahl A, Barroso CP, Andrade NC, Polak JM et al. (1995). Innervation of human epicardial coronary veins: immunohistochemistry and vasomotility. Cardiovasc Res 29: 463-468.
45. Sausbier M, Schubert R, Voigt V, Hirneiss C, Pfeifer A, Korth M et al. (2000). Mechanisms of NO/cGMP-dependent vasorelaxation. Circ Res 87: 825-830.
46. Tiefenbacher CP, Chilian WM (1998). Heterogeneity of coronary vasomotion. Basic Res Cardiol 93: 446-454.
47. Tune JD, Gorman MW, Feigl EO (2004). Matching coronary blood flow to myocardial oxygen consumption. J Appl Physiol 97: 404-415.
48. Väänänen AJ, Kankuri E, Rauhala P (2005). Nitric oxide-related species-induced protein oxidation: Reversible, irreversible, and protective effects on enzyme function of papain. Free Radic Biol Med 38: 1102-1111.
49. Walsh MP, Kargacin GJ, Kendrick-Jones J, Lincoln TM (1995). Intracellular mechanisms involved in the regulation of vascular smooth muscle tone. Can J Physiol Pharmacol 73: 565-573.
50. B-receptor mediated contraction of rat pulmonary arteries. Am J Physiol 290: L570-L578.
51. Zhang RZ, Yang Q, Yim AP, Huang Y, He GW (2004). Different role of nitric oxide and endothelium-derived hyperpolarizing factor in endothelium-dependent hyperpolarization and relaxation in porcine coronary arterial and venous system. J Cardiovasc Pharmacol 43: 839-850.